Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells
Junya Ichikawa, Tatsuya Yoshida, Ariel Isser, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 13, pp. 3384-3396
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Emerging vaccine nanotechnology: From defense against infection to sniping cancer
Chan Feng, Yongjiang Li, Bijan Emiliano Ferdows, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2206-2223
Open Access | Times Cited: 89
Nanotechnology-enhanced immunotherapy for metastatic cancer
Peisen Zhang, Junli Meng, Yingying Li, et al.
The Innovation (2021) Vol. 2, Iss. 4, pp. 100174-100174
Open Access | Times Cited: 69
Engineering Nanoscale Artificial Antigen-Presenting Cells by Metabolic Dendritic Cell Labeling to Potentiate Cancer Immunotherapy
Ping Xiao, Jue Wang, Zitong Zhao, et al.
Nano Letters (2021) Vol. 21, Iss. 5, pp. 2094-2103
Closed Access | Times Cited: 64
Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
Leila Pourtalebi Jahromi, Mohammad‐Ali Shahbazi, Aziz Maleki, et al.
Advanced Science (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 62
Recent advances in biomaterial-boosted adoptive cell therapy
Yonger Xue, Junyi Che, Xuemei Ji, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 5, pp. 1766-1794
Closed Access | Times Cited: 48
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy
Ariel Isser, Natalie K. Livingston, Jonathan P. Schneck
Biomaterials (2020) Vol. 268, pp. 120584-120584
Open Access | Times Cited: 60
Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment
Chunxiong Zheng, Jiabin Zhang, Hon Fai Chan, et al.
Small Methods (2021) Vol. 5, Iss. 5
Closed Access | Times Cited: 42
DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy
Lele Sun, Fengyun Shen, Zijian Xiong, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 17, pp. 7634-7645
Closed Access | Times Cited: 36
Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications
Rong Jiao, Xia Lin, Qian Zhang, et al.
Progress in Materials Science (2023) Vol. 142, pp. 101230-101230
Closed Access | Times Cited: 20
Nanomaterials Boost CAR‐T Therapy for Solid Tumors
Jun Long, Yian Wang, Xianjie Jiang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 7
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
Antigen-Presenting Cells: Potential of Proven und New Players in Immune Therapies
Britta Eiz‐Vesper, Helga Schmetzer
Transfusion Medicine and Hemotherapy (2020) Vol. 47, Iss. 6, pp. 429-431
Open Access | Times Cited: 38
Nanomaterials to improve cancer immunotherapy based on ex vivo engineered T cells and NK cells
Bohwa Han, Yeonju Song, Jeehun Park, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 379-391
Closed Access | Times Cited: 19
Influence of different conjugation methods for activating antibodies on polymeric nanoparticles: Effects for polyclonal expansion of human CD8+ T cells
Sven Weller, Xin Li, Lars Ringgaard, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111643-111643
Open Access | Times Cited: 4
ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs
Luo Siwei, Amber Notaro, Lan Lin
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
Ruichen Huang, Zhao Bi, Shi Hu, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Immunomodulatory Nanoparticles Activate Cytotoxic T cells for Enhancement of the Effect of Cancer Immunotherapy
Kory Wells, Tongrui Liu, Lei Zhu, et al.
Nanoscale (2024) Vol. 16, Iss. 38, pp. 17699-17722
Open Access | Times Cited: 3
Nanoparticles for generating antigen-specific T cells for immunotherapy
Savannah Est-Witte, Natalie K. Livingston, Mary O. Omotoso, et al.
Seminars in Immunology (2021) Vol. 56, pp. 101541-101541
Open Access | Times Cited: 23
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Siri Tvingsholm, Marcus Svensson, Vibeke Mindahl Rafa, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e006847-e006847
Open Access | Times Cited: 7
Genetically engineered CD80–pMHC-harboring extracellular vesicles for antigen-specific CD4+ T-cell engagement
Irina A. Ishina, Inna N. Kurbatskaia, A. E. Mamedov, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 11
Open Access | Times Cited: 2
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
Ariel Isser, Aliyah B. Silver, Hawley C. Pruitt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR
Sara M. O’Rourke, Giora I. Morozov, Jacob T. Roberts, et al.
Protein Engineering Design and Selection (2019) Vol. 32, Iss. 12, pp. 525-532
Open Access | Times Cited: 14
Immunogenicity of Non-mutated Ovarian Cancer-Specific Antigens
Leslie Hesnard, Catherine Thériault, M Cahuzac, et al.
(2024)
Open Access | Times Cited: 1
Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens
Leslie Hesnard, Catherine Thériault, M Cahuzac, et al.
Current Oncology (2024) Vol. 31, Iss. 6, pp. 3099-3121
Open Access | Times Cited: 1
A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T-cell-based immunotherapy
Yue Wu, Xiao Liang, Yanping Sun, et al.
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200827-200827
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top